Reiter's syndrome after intravesical Bacillus calmette-guerin therapy for bladder cancer

Israel Medical Association Journal

Volumn 2, Issue 3, 2000, Pages 240-241

  Hodish, I ^a   Ezra, D ^a   Gur, H ^a   Strugo, R ^a   Olchovsky, D ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

BCG; Bladder cancer; HLA B27; Reactive arthritis; Reiter's syndrome

Indexed keywords

BCG VACCINE; CALCIUM CHANNEL BLOCKING AGENT; HLA B27 ANTIGEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; PREDNISONE; SULFONYLUREA; TETRACYCLINE;

AGED; ANGINA PECTORIS; ARTICLE; BCG VACCINATION; BLADDER CANCER; CASE REPORT; DIABETES MELLITUS; HUMAN; HYPERTENSION; KIDNEY PELVIS CARCINOMA; MALE; REACTIVE ARTHRITIS; REITER SYNDROME; TRANSITIONAL CELL CARCINOMA; TREATMENT FAILURE;

ADMINISTRATION, INTRAVESICAL; AGED; BCG VACCINE; HUMANS; MALE; REITER SYNDROME; URINARY BLADDER NEOPLASMS;

EID: 0033839011     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Incidence and treatment of Bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer
2. Polyarthritis in 4 patients treated with intravesical BCG therapy for carcinoma of the bladder
3. Reiter's syndrome after intravesical Bacillus Calmette-Guerin treatment for superficial bladder carcinoma
4. Arthritis induced by a T-lymphocyte clone that respond to Mycobacterium tuberculosis and to cartilage proteoglycans
5. HLA-DR expression by high grade superficial bladder cancer treated with BCG